PRECLINICAL PHARMACOLOGY OF A NEW SEROTONERGIC RECEPTOR ANTAGONIST, LY281067

被引:0
|
作者
COHEN, ML
FULLER, RW
KURZ, KD
PARLI, CJ
MASON, NR
MEYERS, DB
SMALLWOOD, JK
TOOMEY, RE
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:106 / 112
页数:7
相关论文
共 50 条
  • [21] PHARMACOLOGY AND CLINICAL EFFICACY OF RANITIDINE, A NEW H-2-RECEPTOR ANTAGONIST
    HELMAN, CA
    TIM, LO
    PHARMACOTHERAPY, 1983, 3 (04): : 185 - 192
  • [22] Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia
    Roch, Catherine
    Bergamini, Giorgio
    Steiner, Michel A.
    Clozel, Martine
    PSYCHOPHARMACOLOGY, 2021, 238 (10) : 2693 - 2708
  • [23] In vivo pharmacology of the new angiotensin II receptor antagonist KRH-594
    Murakami, M
    Inada, Y
    Tazawa, S
    Wang, JX
    Nakao, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R275 - R275
  • [24] Discovery and preclinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, CP-336156, a diaryltetrahydronaphthalene
    Rosati, RL
    Jardine, PD
    Cameron, KO
    Thompson, DD
    Ke, HZ
    Toler, SM
    Brown, TA
    Pan, LC
    Ebbinghaus, CF
    Reinhold, AR
    Elliott, NC
    Newhouse, BN
    Tjoa, CM
    Sweetnam, PM
    Cole, MJ
    Arriola, MW
    Gauthier, JW
    Crawford, DT
    Nickerson, DF
    Pirie, CM
    Qi, H
    Simmons, HA
    Tkalcevic, GT
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (16) : 2928 - 2931
  • [25] Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia
    Catherine Roch
    Giorgio Bergamini
    Michel A. Steiner
    Martine Clozel
    Psychopharmacology, 2021, 238 : 2693 - 2708
  • [26] PHARMACOLOGY AND CLINICAL EFFICACY OF TERFENADINE, A NEW H1-RECEPTOR ANTAGONIST
    CONNELL, JT
    PHARMACOTHERAPY, 1985, 5 (04): : 201 - 208
  • [27] SYNTHESIS OF NMDA RECEPTOR ANTAGONIST LY235959
    BERTSCH, CF
    KHAU, VV
    HANSEN, MM
    HARKNESS, AR
    HUFF, BE
    HUTCHISON, DR
    MARTINELLI, MJ
    MISNER, JW
    PETERSON, BC
    RIECK, JA
    SULLIVAN, KA
    WRIGHT, IG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 409 - ORGN
  • [28] NEFAZODONE - PRECLINICAL PHARMACOLOGY OF A NEW ANTIDEPRESSANT
    EISON, AS
    EISON, MS
    TORRENTE, JR
    WRIGHT, RN
    YOCCA, FD
    PSYCHOPHARMACOLOGY BULLETIN, 1990, 26 (03) : 311 - 315
  • [29] Pharmacology of the endothelinA receptor antagonist:: LU 135252
    Rohmeiss, P
    Birck, R
    Braun, C
    Münter, K
    van der Woude, FJ
    Kirchengast, M
    CARDIOVASCULAR DRUG REVIEWS, 1998, 16 (04): : 391 - 412
  • [30] THE ALPHA-1-ADRENOCEPTOR ANTAGONIST PROFILE OF DOXAZOSIN - PRECLINICAL PHARMACOLOGY
    ALABASTER, VA
    DAVEY, MJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 : S9 - S17